Pacific Biosciences of California, Inc. Operating Lease, Liability, Noncurrent
Pacific Biosciences of California, Inc. (PACB) had Operating Lease, Liability, Noncurrent of $60.42 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $60.42M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $59.00M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $56.59M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $54.30M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $60.42M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $59.00M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $56.59M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $54.30M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $52.08M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $50.48M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $14.91M 10-K · filed 2026-02-25 |
| 2024-09-30 | $16.93M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $19.62M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $29.05M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $31.61M 10-K · filed 2025-03-17 |
| 2023-09-30 | $34.10M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $36.60M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $38.97M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $41.07M 10-K · filed 2024-02-28 |
| 2022-09-30 | $43.16M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $45.50M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $47.74M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $49.97M 10-K · filed 2023-02-28 |
| 2021-09-30 | $49.95M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $35.43M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $36.48M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $37.67M 10-K · filed 2022-02-28 |
| 2020-09-30 | $38.79M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $39.86M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $40.90M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $41.96M 10-K · filed 2021-02-26 |
| 2019-09-30 | $42.97M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $43.92M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $44.86M 10-Q · filed 2019-05-03 |
| 2019-01-01 | $45.80M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |